Purpose. To test the hypothesis that the pharmacokinetics of d-methylphenid
ate (d-MPH) would be altered by food ingested before administration of an i
mmediate release formulation (dl-MPH- IR) but not when food is ingested bef
ore a slow release formulation (dl-MPH-SR).
Methods. A randomized, four-phase, open label, crossover design was conduct
ed in 24 healthy men who each received, on separate occasions, dl-MPH-IR an
d dl-MPH-SR taken after an overnight fast and 15 min after a standardized b
reakfast (20% protein, 21% fat, 59% carbohydrate). Plasma MPH levels were m
onitored by a validated, stereoselective, GLC-ECD method.
Results. For plasma d-MPH, there were significant differences (ANOVA) betwe
en dl-MPH-IR kind dl-MPH-SR in tmax, Cmax (peak exposure), and Cmax/AUC (se
nsitive to rate of absorption). Dl-MPH-SR on average delayed tmax from 2.3
to 3.7 h and lowered Cmax 34%. There was no significant difference between
the formulations in AUC (extent of absorption). For dl-MPH-IR, food signifi
cantly increased Cmax (23%) and AUC (15%) and for dl-MPH-SR the correspondi
ng increases were Cmax (17%) and AUC (14%). After dl-MPI-I-IR, food delayed
average tmax from 2.0 to 2.5 but had no effect on tmax after dl-MPH-SR. Th
ere was no effect of food on Cmax/AUC (rate of absorption).
Conclusions. Food caused a significant increase in extent of absorption but
had no effect on rate of absorption of d-MPH after either dl-MPH1R or di-M
PI-I-SR.